-
-
-
-
-
-
-
Allarity Therapeutics (ALLR) Receives Australian Patent Acceptance Notice for Stenoparib DRPĀ® Companion Diagnostic
-
-
-
-
-
-
-
Allarity Therapeutics (ALLR) Announces Final Settlement with the U.S. Securities and Exchange Commission
-
-
-
-
-
-
-
Allarity Therapeutics (ALLR) Regains Compliance with NASDAQ Minimum Bid Price Requirement
-
-
-
-
-
-
-
Allarity Therapeutics (ALLR) Granted Hearing to Regain Nasdaq Compliance
353,174 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

